Induced pluripotent stem cells and disorders of the nervous system: Progress, problems, and prospects

Neuroscientist

Volumn 19, Issue 6, 2013, Pages 567-577

  Faiz, Maryam ^a   Nagy, Andras ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

direct cell fate conversion; induced pluripotent stem cells (IPSC); neurodegenerative disease; reprogramming

Indexed keywords

3 (3,5 DIBROMO 4 HYDROXYBENZYLIDENE) 1,3 DIHYDRO 5 IODO 2 INDOLONE; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX2;

ALLOGRAFT; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL TYPE; DEGENERATIVE DISEASE; DRUG DEVELOPMENT; DRUG SCREENING; EMBRYONIC STEM CELL; HUMAN; IN VIVO STUDY; NERVE CELL; NERVOUS SYSTEM; NONHUMAN; NUCLEAR REPROGRAMMING; ONCOGENE C MYC; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SAFETY; SOMATIC CELL;

EID: 84887415044     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858413493148     Document Type: Article

References (78)

1. Addis RC, Hsu FC, Wright RL, Dichter MA, Coulter DA, Gearhart JD. Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector. PLoS One. 2011 ; 6 ( 12 ):
2. Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol. 2011 ; 29 (12). 1132-44
3. An MC, Zhang N, Scott G, Montoro D, Wittkop T, Mooney S. Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells. Cell Stem Cell. 2012 ; 11 (2). 253-63
4. Andersson E, Tryggvason U, Deng Q, Friling S, Alekseenko Z, Robert B. Identification of intrinsic determinants of midbrain dopamine neurons. Cell. 2006 ; 124 (2). 393-405
5. Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI. Embryonic stem cells express neuronal properties in vitro. Dev Biol. 1995 ; 168 (2). 342-57
6. Baker DE, Harrison NJ, Maltby E, Smith K, Moore HD, Shaw PJ. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol. 2007 ; 25 (2). 207-15
7. Bellin M, Marchetto MC, Gage FH, Mummery CL. Induced pluripotent stem cells: the new patient?. Nat Rev Mol Cell Biol. 2012 ; 13 (11). 713-26
8. Blau HM, Chiu CP, Webster C. Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell. 1983 ; 32 (4). 1171-80
9. Blau HM, Pavlath GK, Hardeman EC, Chiu CP, Silberstein L, Webster SG. Plasticity of the differentiated state. Science. 1985 ; 230 (4727). 758-66
10. Boulting GL, Kiskinis E, Croft GF, Amoroso MW, Oakley DH, Wainger BJ. A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol. 2011 ; 29 (3). 279-86
11. Caiazzo M, Dell'Anno MT, Dvoretskova E, Lazarevic D, Taverna S, Leo D. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature. 2011 ; 476 (7359). 224-7
12. Camnasio S, Carri AD, Lombardo A, Grad I, Mariotti C, Castucci A. The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol Dis. 2012 ; 46 (1). 41-51
13. Chen S, Xu Y, Chen Y, Li X, Mou W, Wang L. SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. PLoS One. 2012 ; 7 (5). e36326
14. Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell. 2009 ; 5 (1). 111-23
15. Cooper O, Seo H, Andrabi S, Guardia-Laguarta C, Graziotto J, Sundberg M. Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med. 2012 ; 4 (141). 141ra90
16. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 2008 ; 321 (5893). 1218-21
17. Doetsch F. The glial identity of neural stem cells. Nat Neurosci. 2003 ; 6 (11). 1127-34
18. Ebert AD, Yu J, Rose FF, Mattis VB, Lorson CL, Thomson JA. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2009 ; 457 (7227). 277-80
19. Efe JA, Hilcove S, Kim J, Zhou H, Ouyang K, Wang G. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat Cell Biol. 2011 ; 13 (3). 215-22
20. Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med. 2012 ; 4 (145). 145ra104
21. Freeman MR. Specification and morphogenesis of astrocytes. Science. 2010 ; 330 (6005). 774-8
22. Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci. 2009 ; 85 (8). 348-62
23. Gaspard N, Bouschet T, Herpoel A, Naeije G, van den Ameele J, Vanderhaeghen P. Generation of cortical neurons from mouse embryonic stem cells. Nat Protoc. 2009 ; 4 (10). 1454-63
24. Gaspard N, Bouschet T, Hourez R, Dimidschstein J, Naeije G, van den Ameele J. An intrinsic mechanism of corticogenesis from embryonic stem cells. Nature. 2008 ; 455 (7211). 351-7
25. Gonzalez F, Boue S, Izpisua Belmonte JC. Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat Rev Genet. 2011 ; 12 (4). 231-42
26. Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J. Somatic coding mutations in human induced pluripotent stem cells. Nature. 2011 ; 471 (7336). 63-7
27. Grskovic M, Javaherian A, Strulovici B, Daley GQ. Induced pluripotent stem cells - opportunities for disease modelling and drug discovery. Nat Rev Drug Discov. 2011 ; 10 (12). 915-29
28. Gurdon JB. Adult frogs derived from the nuclei of single somatic cells. Dev Biol. 1962 ; 4: 256-73
29. Hargus G, Cooper O, Deleidi M, Levy A, Lee K, Marlow E. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A. 2010 ; 107 (36). 15921-6
30. Heinrich C, Blum R, Gascon S, Masserdotti G, Tripathi P, Sanchez R. Directing astroglia from the cerebral cortex into subtype specific functional neurons. PLoS Biol. 2010 ; 8 (5). e1000373
31. Hochstim C, Deneen B, Lukaszewicz A, Zhou Q, Anderson DJ. Identification of positionally distinct astrocyte subtypes whose identities are specified by a homeodomain code. Cell. 2008 ; 133 (3). 510-22
32. Hockemeyer D, Wang H, Kiani S, Lai CS, Gao Q, Cassady JP. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol. 2011 ; 29 (8). 731-4
33. Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ, Thomson JA. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A. 2010 ; 107 (9). 4335-40
34. Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Narva E. Copy number variation and selection during reprogramming to pluripotency. Nature. 2011 ; 471 (7336). 58-62
35. Hussein SM, Elbaz J, Nagy AA. Genome damage in induced pluripotent stem cells: Assessing the mechanisms and their consequences. Bioessays. 2013 ; 35 (3). 152-62
36. Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature. 2012 ; 482 (7384). 216-20
37. Karow M, Sanchez R, Schichor C, Masserdotti G, Ortega F, Heinrich C. Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells. Cell Stem Cell. 2012 ; 11 (4). 471-6
38. Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron. 2000 ; 28 (1). 31-40
39. Kim J, Efe JA, Zhu S, Talantova M, Yuan X, Wang S. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci U S A. 2011a ; 108 (19). 7838-43
40. Kim J, Su SC, Wang H, Cheng AW, Cassady JP, Lodato MA. Functional integration of dopaminergic neurons directly converted from mouse fibroblasts. Cell Stem Cell. 2011b ; 9 (5). 413-9
41. Kriks S, Shim JW, Piao J, Ganat YM, Wakeman DR, Xie Z. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature. 2011 ; 480 (7378). 547-51
42. Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ, Gimotty PA. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene. 2012 ; 31 (47). 4898-911
43. Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell. 2011 ; 8 (1). 106-18
44. Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, Fasano CA. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature. 2009 ; 461 (7262). 402-6
45. Lujan E, Chanda S, Ahlenius H, Sudhof TC, Wernig M. Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc Natl Acad Sci U S A. 2012 ; 109 (7). 2527-32
46. Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell. 2010 ; 7 (4). 521-31
47. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol. 2007 ; 25 (10). 1177-81
48. Narva E, Autio R, Rahkonen N, Kong L, Harrison N, Kitsberg D. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol. 2010 ; 28 (4). 371-7
49. Nowak-Imialek M, Niemann H. Pluripotent cells in farm animals: state of the art and future perspectives. Reprod Fertil Dev. 2012 ; 25 (1). 103-28
50. Papadeas ST, Maragakis NJ. Advances in stem cell research for amyotrophic lateral sclerosis. Curr Opin Biotechnol. 2009 ; 20 (5). 545-51
51. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A. Disease-specific induced pluripotent stem cells. Cell. 2008 ; 134 (5). 877-86
52. Perrier AL, Tabar V, Barberi T, Rubio ME, Bruses J, Topf N. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A. 2004 ; 101 (34). 12543-8
53. Pfisterer U, Kirkeby A, Torper O, Wood J, Nelander J, Dufour A. Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A. 2011 ; 108 (25). 10343-8
54. Puri MC, Nagy A. Concise review: embryonic stem cells versus induced pluripotent stem cells: the game is on. Stem Cells. 2012 ; 30 (1). 10-4
55. Robinton DA, Daley GQ. The promise of induced pluripotent stem cells in research and therapy. Nature. 2012 ; 481 (7381). 295-305
56. Rowland BD, Peeper DS. KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer. 2006 ; 6 (1). 11-23
57. Saha K, Jaenisch R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell. 2009 ; 5 (6). 584-95
58. Sanchez-Danes A, Richaud-Patin Y, Carballo-Carbajal I, Jimenez-Delgado S, Caig C, Mora S. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. EMBO Mol Med. 2012 ; 4 (5). 380-95
59. Shi Y, Kirwan P, Smith J, Robinson HP, Livesey FJ. Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat Neurosci. 2012 ; 15 (3). 477 S1-86
60. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. 2009 ; 136 (5). 964-77
61. Son EY, Ichida JK, Wainger BJ, Toma JS, Rafuse VF, Woolf CJ. Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell. 2011 ; 9 (3). 205-18
62. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007 ; 131 (5). 861-72
63. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006 ; 126 (4). 663-76
64. Thier M, Worsdorfer P, Lakes YB, Gorris R, Herms S, Opitz T. Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell. 2012 ; 10 (4). 473-9
65. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS. Embryonic stem cell lines derived from human blastocysts. Science. 1998 ; 282 (5391). 1145-7
66. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature. 2010 ; 463 (7284). 1035-41
67. Watanabe K, Kamiya D, Nishiyama A, Katayama T, Nozaki S, Kawasaki H. Directed differentiation of telencephalic precursors from embryonic stem cells. Nat Neurosci. 2005 ; 8 (3). 288-96
68. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A. 2008 ; 105 (15). 5856-61
69. Wichterle H, Lieberam I, Porter JA, Jessell TM. Directed differentiation of embryonic stem cells into motor neurons. Cell. 2002 ; 110 (3). 385-97
70. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature. 1997 ; 385 (6619). 810-3
71. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hamalainen R. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 2009 ; 458 (7239). 766-70
72. Xie H, Ye M, Feng R, Graf T. Stepwise reprogramming of B cells into macrophages. Cell. 2004 ; 117 (5). 663-76
73. Yagi T, Ito D, Okada Y, Akamatsu W, Nihei Y, Yoshizaki T. Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum Mol Genet. 2011 ; 20 (23). 4530-9
74. Ying QL, Stavridis M, Griffiths D, Li M, Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol. 2003 ; 21 (2). 183-6
75. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin. Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009 ; 324 (5928). 797-801
76. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007 ; 318 (5858). 1917-20
77. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature. 2008 ; 455 (7213). 627-32
78. Zou J, Maeder ML, Mali P, Pruett-Miller SM, Thibodeau-Beganny S, Chou BK. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell. 2009 ; 5 (1). 97-110